We believe access to medicine should be global by design.
Too often, patients are held back by practical barriers, fragmented supply chains or unfamiliarity with complex regulatory routes. These challenges delay access to critical, life-saving treatments, particularly in less well-served markets.
Our purpose is to help remove those barriers.
As pathfinders, we navigate complexity and support access to medicines across the product lifecycle, from clinical trials and early access programs through to long-term commercialisation, using both licensed and unlicensed pathways.
We work in close partnership with pharmaceutical and biotechnology companies, guiding them through practical, regulatory and geographical challenges with experience, judgement and collaboration.
By combining global reach with strong local insight, our teams work together to deliver access where it matters most.
Whatever the challenge, we find a way.
Pharma and biotechs
We work alongside pharma and biotech companies across the lifecycle, shaping decisions that support timely access and long-term patient impact.
How we help pharma & biotechs
Healthcare professionals
We support healthcare professionals through trusted global pathways that help patients receive the medicines they need.
How we help HCPS
Patients and patient groups
We engage with patients and communities to inform how access is delivered and where unmet needs remain.
How we help patients
Wherever your asset is in its journey, we help it reach patients faster
Our global platform supports medicines from development to post-launch access, creating one seamless path to delivery.